8. The Distribution Gauntlet
The Vax Files10 Feb 2021

8. The Distribution Gauntlet

In this eighth episode, The Covax Files takes a mini world tour on some mass vaccinations programs that started in December 2020 and January 2021. Surani speaks to experts in different regions to get a taste of what has been happening on the ground with rollouts in the US, Europe, Israel and India, and the unique strengths and challenges within each region. While the US is facing issues with simply getting vaccinations sites set up to deliver a huge supply of vaccines to patients, the EU is facing the opposite problem with a mobilization plan in place but not enough vaccine to go around. Israel has become the unforeseen world leader of vaccinations after signing a unique data-sharing deal with Pfizer, while India also surprises with some grand plans to not only take care of its 1.3 billion population, but also its neighboring countries. Many countries, especially lower income countries are yet to receive a single vaccine dose, and experts discuss the global distribution challenges that are brought on when rich countries sign private deals to buy doses directly from pharma companies. This episode explores the COVAX facility and how it's set up to ensure equitable access of vaccines across the globe and the broader challenges to counter vaccine nationalism.


Expert Guests:


-- Professor Hani S. Mahmassani is Director at the Northwestern University Transportation Center and William A. Patterson Distinguished Chair in Transportation. He specializes in multimodal transportation systems analysis, large-scale human infrastructure systems, and real-time operation of logistics and distribution systems.


-- Neeraj Jain, MBA, is the director of PATH’s India operations -- an organization dedicated to health equity and part of the COVAX initiative. He oversees all operations in the country and serves as a liaison between the office in India, PATH headquarters, donors, partners, and national-level ministries.


-- Stefan Walzer is the CEO and founder of MArS market access and pricing strategy, based in Germany. Stefan has more than 15 years experience in payer strategy, pricing, health economics and reimbursement submissions.


-- Julia Barnes-Weise is Executive Director of the Global Healthcare Innovation Alliance Accelerator. She is also a Senior Consultant to the Coalition for Epidemic Preparedness and Innovation (CEPI) and has been a Consultant to the WHO.




Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(17)

16. Future Pipeline and Global Outlook

16. Future Pipeline and Global Outlook

Nearly two years after Covid-19 was first detected in Wuhan, the world is still very much in a pandemic. The toughest phase may behind us, but we are still faced with the possibility of new variants o...

1 Des 202136min

15. Virus Evolution and Vaccine Pressure

15. Virus Evolution and Vaccine Pressure

As the world tries to take a hold over the delta variant, we're all watching and waiting to see if the virus is going to evolve into something new. There are fears that natural selection could potenti...

24 Nov 202132min

14. Vaccine Policies: Boosters and Mandates

14. Vaccine Policies: Boosters and Mandates

As governments around the world try to get their countries and economies back on track, they are starting to desperately implement a number of vaccine policies that have sometimes been questioned by s...

17 Nov 202132min

13. Protecting Our Children

13. Protecting Our Children

Vaccination in children has fueled a global expert debate specifically around the risk benefit consideration that some may find acceptable and others may find questionable. While children were largely...

10 Nov 202134min

12. Real World Safety

12. Real World Safety

With around 7 billion doses administered, the vaccines have largely been proven safe, but there are still major concerns around rare serious side-effects and long term safety unknowns. Experts discuss...

3 Nov 202132min

11. Real World Effectiveness

11. Real World Effectiveness

Since the last episode in February, a lot has happened with the vaccination rollout -- so we're back for a few more episodes. But we've changed our name from The CoVax Files to The Vax Files, which wa...

27 Okt 202132min

10. The Last Lingering Questions

10. The Last Lingering Questions

In this final and tenth episode, we'll tackle some of the last lingering questions that we all have around the vaccines and how the future might look as we navigate these uncharted pandemic waters. Ex...

24 Feb 202138min

9. The New Variant Drama

9. The New Variant Drama

In this ninth episode, we'll tackle the different conundrums we face with the emergence of new and highly transmissible SARS-COV-2 variants. Get ready to delve into some thought provoking scientific c...

17 Feb 202135min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
abels-tarn
romkapsel
jss
liberal-halvtime
rekommandert
vett-og-vitenskap-med-gaute-einevoll
sinnsyn
dekodet-2
villmarksliv
rss-rekommandert
fjellsportpodden
tomprat-med-gunnar-tjomlid
rss-overskuddsliv
rss-inn-til-kjernen-med-sunniva-rose
rss-nysgjerrige-norge
kvinnehelsepodden
diagnose
abid-nadia-skyld-og-skam